Atkinson Edward Morrow III
SEC CIK 1914164 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals | EVP, Chief Technical Ops. Off | 18.4K | — | $11.60M | 30 | 2024-02-06 | 2026-02-25 |
Most active insiders at VRTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEIDEN JEFFREY M | Executive COB, Dir | — | $60.94M |
| 2 | Sachdev Amit | EVP Chief Patient, Ext Af Off | — | $28.38M |
| 3 | Kewalramani Reshma | CEO, Pres, Dir | — | $19.74M |
| 4 | Bozic Carmen | EVP, CMO | — | $11.31M |
| 5 | WAGNER CHARLES F JR | EVP, CO, FO | — | $10.78M |
| 6 | Tatsis Ourania | EVP, Chief Reg, Quality Off | — | $6.51M |
| 7 | McKechnie Duncan | EVP, Chief Commercial Off | — | $5.66M |
| 8 | Biller Jonathan | EVP, CLO | — | $4.08M |
| 9 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | — | $3.60M |
| 10 | Bunnage Mark E. | EVP, CSO | — | $3.00M |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-26 | 2026-02-25 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $486.35 | -668 | 18.4K | -3% | -$324.9K | |
| 2026-02-26 | 2026-02-24 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $485.11 | -1,627 | 19.1K | -8% | -$789.3K | |
| 2026-02-19 | 2026-02-17 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | A - Grant | $0.00 | +4,962 | 25.1K | +25% | $0 | |
| 2026-02-19 | 2026-02-17 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $483.75 | -1,530 | 23.6K | -6% | -$740.1K | |
| M | 2026-02-19 | 2026-02-17+ | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $484.93 | -2,848 | 21.5K | -12% | -$1.38M |
| 2026-02-18 | 2026-02-13 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $487.76 | -1,903 | 20.1K | -9% | -$928.2K | |
| 2026-02-12 | 2026-02-10 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $468.41 | -872 | 23.8K | -4% | -$408.5K | |
| 2026-02-12 | 2026-02-11 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $460.43 | -1,751 | 22.0K | -7% | -$806.2K | |
| M | 2026-01-26 | 2026-01-22 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | A - Grant | $0.00 | +7,817 | 24.7K | +46% | $0 |
| 2025-11-19 | 2025-11-17 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $434.58 | -2,500 | 16.9K | -13% | -$1.09M | |
| 2025-02-28 | 2025-02-26 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $479.61 | -2,482 | 22.0K | -10% | -$1.19M | |
| 2025-02-28 | 2025-02-27 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $475.34 | -2,650 | 19.4K | -12% | -$1.26M | |
| 2025-02-26 | 2025-02-25 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $480.95 | -1,767 | 24.5K | -7% | -$849.8K | |
| 2025-02-26 | 2025-02-24 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $483.28 | -1,656 | 26.3K | -6% | -$800.3K | |
| 2025-02-19 | 2025-02-14 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $463.46 | -1,529 | 27.9K | -5% | -$708.6K | |
| 2025-02-14 | 2025-02-12 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | A - Grant | $0.00 | +6,211 | 29.4K | +27% | $0 | |
| 2025-02-12 | 2025-02-10 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $467.98 | -876 | 25.0K | -3% | -$410.0K | |
| 2025-02-12 | 2025-02-11 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $459.83 | -1,747 | 23.2K | -7% | -$803.3K | |
| M | 2025-02-06 | 2025-02-04 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | A - Grant | $0.00 | +9,876 | 25.8K | +62% | $0 |
| 2024-06-13 | 2024-06-11 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $481.96 | -6,824 | 23.3K | -23% | -$3.29M | |
| 2024-06-13 | 2024-06-12 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $478.00 | -7,288 | 16.0K | -31% | -$3.48M | |
| 2024-05-16 | 2024-05-14 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | A - Grant | $0.00 | +14.1K | 30.1K | +88% | $0 | |
| 2024-02-27 | 2024-02-23 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $431.79 | -1,654 | 16.9K | -9% | -$714.2K | |
| 2024-02-27 | 2024-02-26 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $425.70 | -883 | 16.0K | -5% | -$375.9K | |
| 2024-02-23 | 2024-02-21 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $421.77 | -1,201 | 18.5K | -6% | -$506.5K | |
| M | 2024-02-21 | 2024-02-16+ | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $422.54 | -2,626 | 21.6K | -11% | -$1.11M |
| 2024-02-21 | 2024-02-20 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $420.79 | -801 | 19.7K | -4% | -$337.1K | |
| 2024-02-13 | 2024-02-12 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $420.24 | -913 | 23.1K | -4% | -$383.7K | |
| 2024-02-13 | 2024-02-09 | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $422.74 | -832 | 24.1K | -3% | -$351.7K | |
| M | 2024-02-08 | 2024-02-06+ | VRTX | Vertex Pharmaceuticals | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | A - Grant | $0.00 | +11.0K | 20.1K | +120% | $0 |
Purchase Sale Sale after option exercise All abbreviations